000			01639 a2200445 4500
005			20250512023101.0
264		0	_c19860606
008			198606s 0 0 eng d
022			_a0022-1767
040			_aNLM _beng _cNLM
100	1		_aMulé, J J
245	0	0	_aThe anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cMay 1986
300			_a3899-909 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntigens, Surface _xanalysis
650	0	4	_aCell Differentiation
650	0	4	_aCytotoxicity, Immunologic _xradiation effects
650	0	4	_aFemale
650	0	4	_aImmunity, Cellular _xradiation effects
650	0	4	_aImmunization, Passive
650	0	4	_aImmunotherapy
650	0	4	_aInterleukin-2 _xtherapeutic use
650	0	4	_aKiller Cells, Natural _ximmunology
650	0	4	_aLung _xcytology
650	0	4	_aLung Neoplasms _xsecondary
650	0	4	_aLymphokines _xtherapeutic use
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aSarcoma, Experimental _ximmunology
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
650	0	4	_aThy-1 Antigens
650	0	4	_aThymectomy
700	1		_aYang, J
700	1		_aShu, S
700	1		_aRosenberg, S A
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 136 _gno. 10 _gp. 3899-909
999			_c2876952 _d2876952